TLR4 and colonic neoplasm: Accordingly, mice with toll-like receptor 4 (TLR4, a receptor for bacterial lipopolysaccharide) constitutively activated registered colitis-associated neoplasia more often than WT counterparts [54], while TLR4 knockout animals developed significantly less colonic tumors when compared to controls [55].